ALSV
ATP Life Science Ventures Portfolio holdings
AUM
$898M
1-Year Est. Return
84.86%
1 Year Est. Return
+84.86%
AUM
$898M
AUM Growth
-$397M
(-31%)
Holding
3
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stoke Therapeutics
STOK
$1.81B
| $667M | 74.2% |
17,161,713
|
|
||
2
Akero Therapeutics
AKRO
$4.32B
| $169M | 18.83% |
5,830,203
|
|
||
|
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $62.6M | 6.97% |
4,028,937
|
|